Maricann Group Inc. (CSE:MARI)(OTCQB:MRRCF) announced this morning that the company has received its Good Manufacturing Practice (GMP) certification from the European Medicines Agency.
The Maricann Group is a vertically integrated, public cannabis company located in Ontario, Canada. The company currently operates cultivation, extraction, formulation and distribution facilities in accordance with federal law in Canada.
The company started the difficult process of obtaining their GMP certification back in the Q4 of 2017. Health inspectors visited the Maricann Group’s facility in Langton, Ontario where the company is currently expanding their operations to house 942,000 sq. ft. of production and processing space.
Maricann is one of only 6 different medical marijuana producers in Canada that’s have obtained their GMP certification. By obtaining this, the Maricann Group qualifies to now export medicinal cannabis onto the continent of Europe.
Ben Ward, CEO of the company, gave this statement in the press release:
“EMA-GMP certification of our cultivation facility in Canada demonstrates further progress at Maricann. External validation of our operations provides comfort to our patients and consumers that we exceed industry standards. Our commitment to total quality, from origination to finished product is now certified.”
You may be interested
Liberty Health Sciences to Bring Mary’s Medicinals Cannabis Products to MassachusettsSam Rosenberg - May 26, 2018
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) announced this week that the company will expand the Company’s partnership with MM Technology Holdings, LLC to become the…
Top 5 Public Companies that Sells Cannabis and Industrial Hemp AgtechSam Rosenberg - May 25, 2018
Not every public company in the sector are involved in the cultivation and distribution of cannabinoid based products. There are a number of different companies involved in…
Thomas Jefferson University to Create Database to Track Medical Cannabis Patients’ Health OutcomesSam Rosenberg - May 25, 2018
Thomas Jefferson University in Philadelphia is in the process of developing a data base to register medical cannabis patients to study the positive or negative health benefits…